RxDoctor Payments Data

Michael Adornetto, DO

Internal Medicine · Westlake, OHNPI 1235139767

Payments from drug & device makers

$4,454in general payments, 2019–2025

Across 247 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$556
  • Novo Nordisk$333
  • Lilly USA, LLC$286
  • AstraZeneca$251
  • Merck$238
  • Abbott$202
  • plus $3K from 46 others

What the payments were for

  • Food & beverage$4,37998%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,454 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$71,726
Medicare patients
127
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin101$97,970
EliquisApixaban77$80,963
MounjaroTirzepatide60$64,947
OzempicSemaglutide60$60,456
JanuviaSitagliptin Phosphate44$42,919
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$32,378
FarxigaDapagliflozin Propanediol42$31,155
TrulicityDulaglutide25$29,551
XareltoRivaroxaban19$24,746
MyrbetriqMirabegron17$13,636
Breo ElliptaFluticasone/Vilanterol13$7,271
EntrestoSacubitril/Valsartan14$6,080
Atorvastatin Calcium348$3,338
Gabapentin115$2,457
Metoprolol Succinate172$2,057

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$130$97,970101 claims
Lilly USA, LLCMounjaro, Trulicity$286$94,49885 claims
PfizerEliquis$194$80,96377 claims
Novo NordiskOzempic$333$60,45660 claims
MerckJanuvia$238$42,91944 claims
GSKTrelegy Ellipta, Breo Ellipta$160$39,64942 claims
AstraZenecaFarxiga$251$31,15542 claims
Johnson & JohnsonXarelto$90$24,74619 claims
Astellas Pharma US IncMyrbetriq$153$13,63617 claims
NovartisEntresto$13$6,08014 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$1,735192 claims
AbbVieArmour Thyroid, Synthroid$556$1,57435 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Westlake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →